Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinics in Colon and Rectal Surgery|February 7, 2024
Quality of Life Outcomes in Stage IV Colorectal CancerCyrus Ali Feizpour, Anita Turk, Sanjay Mohanty
Current Oncology Reports|March 29, 2022
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of RechallengeLaura B Vater, Bénédicte Lefebvre, Anita Turk, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|July 10, 2025
Early-Onset Colorectal Cancer: From Genetic Discovery to Clinical InnovationAnita Turk, Sebastián Mondaca, Bruno Nervi, et al.
Molecular Cell|July 6, 2011
Mammalian hyperplastic discs homolog EDD regulates miRNA-mediated gene silencingHong Su, Shuxia Meng, Yanyan Lu, et al.
The Oncologist|June 3, 2024
Longitudinal patient-reported outcomes on genotype-guided irinotecan dosing: feasibility and clinical relevanceJonathan D Sorah, Allison M Deal, Sophia I Stein, et al.
Surgery|October 2, 2024
Staging accuracy in patients with clinical T2N0 gastric cancer: Implications for treatment sequencingJackson A Baril, Brian M Ruedinger, Trang K Nguyen, et al.
Future Oncology (London, England)|September 27, 2023
A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinomaRuchi Singhal, Sherise C Rogers, Ji-Hyun Lee, et al.
The Oncologist|June 5, 2024
A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancerHanna K Sanoff, Allison M Deal, Jai Patel, et al.
Nature Genetics|September 18, 2024
Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneityAteeq M Khaliq, Meenakshi Rajamohan, Omer Saeed, et al.
Genome Biology|May 10, 2022
Refining colorectal cancer classification and clinical stratification through a single-cell atlasAteeq M Khaliq, Cihat Erdogan, Zeyneb Kurt, et al.
Pageof 2